Best Agrolife Limited — Investor Meet, 01-06-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Best Agrolife reported FY26 revenue down 31% to ₹1,257 Cr, with PAT at ₹9 Cr. Q4 registered a negative PAT of ₹37 Cr, impacted by weak demand and rising input costs. Inventory reduced significantly to ₹651 Cr.

Management attributed FY26 challenges to unseasonal weather and high channel inventory. For FY27, the focus is on strengthening the patented product portfolio with new launches like Fluzam, introducing bio stimulants, and ramping up in-house technical manufacturing. Pricing actions in April/May are expected to support Q1 FY27 profitability. International expansion is underway with new registrations. Management expresses confidence in strategic actions for sustainable growth.